Verde Servicos Internacionais S.A. Raises Position in Intuitive Surgical, Inc. $ISRG

Verde Servicos Internacionais S.A. boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,988 shares of the medical equipment provider’s stock after buying an additional 2,542 shares during the period. Intuitive Surgical accounts for about 2.7% of Verde Servicos Internacionais S.A.’s portfolio, making the stock its 17th largest holding. Verde Servicos Internacionais S.A.’s holdings in Intuitive Surgical were worth $8,753,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. Wealth Management Partners LLC lifted its position in shares of Intuitive Surgical by 1.7% in the first quarter. Wealth Management Partners LLC now owns 2,134 shares of the medical equipment provider’s stock valued at $984,000 after acquiring an additional 36 shares in the last quarter. Total Clarity Wealth Management Inc. increased its position in shares of Intuitive Surgical by 6.4% during the first quarter. Total Clarity Wealth Management Inc. now owns 1,114 shares of the medical equipment provider’s stock worth $514,000 after purchasing an additional 67 shares in the last quarter. Signal Advisors Wealth LLC raised its stake in Intuitive Surgical by 11.1% in the 1st quarter. Signal Advisors Wealth LLC now owns 9,016 shares of the medical equipment provider’s stock valued at $4,156,000 after purchasing an additional 904 shares during the last quarter. SVB Wealth LLC raised its stake in Intuitive Surgical by 2.5% in the 1st quarter. SVB Wealth LLC now owns 13,718 shares of the medical equipment provider’s stock valued at $6,324,000 after purchasing an additional 331 shares during the last quarter. Finally, Anchyra Partners LLC lifted its holdings in Intuitive Surgical by 3.0% in the 1st quarter. Anchyra Partners LLC now owns 940 shares of the medical equipment provider’s stock valued at $433,000 after purchasing an additional 27 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the sale, the executive vice president owned 5,720 shares in the company, valued at approximately $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,169 shares of company stock worth $3,059,135 over the last quarter. 0.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on ISRG shares. TD Cowen lowered their target price on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Jefferies Financial Group reduced their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research report on Wednesday, April 22nd. Truist Financial lowered their price target on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a research report on Wednesday, April 15th. Bank of America dropped their price objective on shares of Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Finally, Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, June 13th. Nineteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $573.42.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical raised its 2026 outlook after strong first-quarter results, with management increasing da Vinci procedure growth guidance to 13.5%-15.5% from 13%-15%, signaling continued adoption of its robotic surgery platform. Article Title
• Positive Sentiment: Recent commentary suggests the stock may be undervalued after its recent share-price weakness, with some analysis arguing the pullback has reset expectations and could improve long-term upside potential. Article Title
• Neutral Sentiment: ISRG has been a trending stock among investors, which shows elevated attention but does not by itself change the company’s fundamentals. Article Title
• Neutral Sentiment: Some investors are viewing Intuitive Surgical as a hedge against market risk, reflecting the company’s perceived defensive qualities and durable medical-device business model. Article Title
• Negative Sentiment: Jim Cramer said Intuitive Surgical faces “too much competition,” reinforcing investor concerns that rivals could pressure the company’s leadership position and future growth. Article Title
• Negative Sentiment: Additional articles highlighted recent stock weakness, valuation concerns, FDA scrutiny, product recalls, leadership changes, and a bearish Deutsche Bank price target cut to $366, all of which could be weighing on sentiment. Article Title

Intuitive Surgical Stock Performance

ISRG stock opened at $403.18 on Wednesday. The firm has a market cap of $142.79 billion, a PE ratio of 48.87, a PEG ratio of 3.28 and a beta of 1.46. The firm’s 50 day moving average price is $436.44 and its 200-day moving average price is $487.58. Intuitive Surgical, Inc. has a one year low of $396.68 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.81 earnings per share. Equities research analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.